BUBS move to partner with being mate to produce a BUBS SAMR approved product that focuses on China’s lower tier cities is a smart move considering sales in infant formula is expected to be higher then 1st and 2nd tier cities. Also not to mention that since COVID 19 vitamin sales have increased 94%. I would say management are doing their research and have positioned themselves perfectly to take full advantage of this.
Bubs share price climb higer than A2M is not a dream, page-634
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.005(3.13%) |
Mkt cap ! $147.3M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 15.5¢ | $284.7K | 1.784M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 1448141 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 1293461 | 24 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| BUB (ASX) Chart |